12h
Fintel on MSNRoth MKM Downgrades Altus Power (AMPS)Fintel reports that on March 21, 2025, Roth MKM downgraded their outlook for Altus Power (NYSE:AMPS) from Buy to Neutral.
Roth MKM keeps a Buy rating and $20 price target on Riot Platforms (RIOT) after meeting with its CEO at the 37th Annual ROTH Conference.
In a report released today, Nick Anderson from Roth MKM maintained a Buy rating on Ispire Technology, Inc. (ISPR – Research Report), with a ...
Roth MKM lowered the firm’s price target on PSQ Holdings (PSQH) to $4 from $5 and keeps a Buy rating on the shares. The firm ...
Research analysts at Roth Capital issued their Q1 2025 EPS estimates for shares of Gogo in a research note issued on Monday, ...
Rezolve AI (NASDAQ:RZLV – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at Roth Mkm in a ...
Fintel reports that on March 17, 2025, Roth MKM initiated coverage of EZCORP (NasdaqGS:EZPW) with a Buy recommendation.
Analysts expect the Houston, Texas-based company to report quarterly loss at 8 cents per share. Intuitive Machines projects ...
Roth MKM says Semtech (SMTC) reported Q4 beat and Q1 guidance raise driven by data center strength as well as a recovery in ...
Financial giants have made a conspicuous bearish move on D-Wave Quantum. Our analysis of options history for D-Wave Quantum ...
In addition to Roth MKM, Alphabet Class A also received a Buy from Canaccord Genuity’s Maria Ripps in a report issued today. However, yesterday, Monness maintained a Hold rating on Alphabet ...
Detailed price information for Gain Therapeutics Inc (GANX-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results